Latest News
Conference Coverage
VIDEO: Guselkumab bests placebo in psoriatic arthritis
MADRID – The IL-23 blocker bested placebo on ACR 20 response and each secondary endpoint.
Conference Coverage
Pain often persists despite biologic treatment in PsA
MADRID – Psoriatic arthritis patients may have more than just inflammatory pain symptoms.
News
Adalimumab outperforms methotrexate in treating severe pediatric plaque psoriasis
A phase III study provided promising data on the efficacy of adalimumab in children and adolescents with severe plaque psoriasis.
Conference Coverage
Some data support botulinum toxin for psoriasis and rosacea
ORLANDO – Can psoriasis and rosacea symptoms be significantly improved with neuromodulator treatment?
Conference Coverage
How to get the most out of methotrexate for psoriasis
WAILEA, HAWAII – Methotrexate is the most cost-effective way to manage extensive psoriasis.
News
Secukinumab beat etanercept in 52-week psoriasis quality of life analysis
Secukinumab was associated with faster and greater improvements in self-reported quality of life in psoriasis patients, compared with etanercept...
Conference Coverage
What’s old is new in topical psoriasis therapy
WAILEA, HAWAII – Fixed-combination halobetasol/tazarotene lotion proves safe and effective in phase II study.
News
Shingles vaccine deemed effective in people with autoimmune disease
Older adults with an autoimmune disease benefited for about 5 years before the vaccine’s effectiveness began to wane.
Conference Coverage
Clinicians still seek the best uses for apremilast
WAILEA, HAWAII – An expert calls apremilast outmatched for moderate to severe disease, but off-label use for moderate disease and other...
News
CDC: Greater activity limitations accompany rising arthritis prevalence
Physical activity and weight loss may help patients with arthritis retain a higher range of motion.